(Press-News.org)
Melbourne researchers have discovered gender-affirming hormone therapy can alter body proteins to match a person’s gender identity, potentially affecting susceptibility to certain health conditions.
The research, led by Murdoch Children’s Research Institute (MCRI) and the University of Melbourne, found that sex-specific blood proteins in transgender women shifted significantly after six months of gender-affirming hormone therapy, resembling those of cisgender women.
MCRI Associate Professor Boris Novakovic said remarkably the therapy reduced protein biomarkers related to male reproduction and fertility and increased those that drive body fat, breast development, immune function and good heart health.
Published in Nature Medicine, the study involved 40 adult trans women recruited from the Austin Hospital who had more than 5,000 blood proteins examined. Participants were given one of two forms of common feminising hormone therapies with the results checked before and six months of treatment. The research team also compared the protein changes to those seen in cisgender women by using samples from 55,000 people stored in a UK biobank.
It found gender-affirming hormone therapy changed seven of the 10 key proteins that are normally different between males and females, proving that sex hormones strongly influence blood biomarkers to help better align with a person’s gender identity. The changes reflected those seen in women undergoing hormone replacement therapy for menopausal symptoms.
Associate Professor Novakovic said the findings showed changes to sex hormones induced by gender-affirming hormone therapy could have a big influence on reshaping key blood biomarkers that were linked to certain health conditions.
“For transgender women we found gender affirming hormone therapy alters the levels of many protein biomarkers that reflect what happens clinically,” he said. “This may go onto impact the risk of allergic and autoimmune diseases, which tend to affect more females, but decrease the risk of heart disease, more commonly seen in males. This highlights that human biology is malleable and that even in adulthood, our bodies respond to sex hormone changes.”
Associate Professor Novakovic said the findings stressed the need for more nuanced approaches to long-term health monitoring for those undergoing gender-affirming hormone therapy.
Additionally, healthcare providers should consider the similarities to cisgender women’s health risks and the unique aspects of trans women’s health, he said.
University of Melbourne Professor Ada Cheung said, “Studying proteins could help with the development of personalised treatment approaches by monitoring the effectiveness of gender affirming hormone therapy in trans women and help us with early detection of potential side-effects on heart health or immune function.
“We need to improve the way gender-affirming hormone therapy is managed. This study gives us a glimpse into how personalised treatment may work as technology advances.”
Publication: Nhi NL Nguyen, Den Celestra, Lachlan M. Angus, Toby Mansell, Rebecca Shepherd, Bo Won Kim, Bridget Arman, Georgiana Cabau, Tania O. Crișan, Leo A. B. Joosten, Camille Laberthonnière, David Burgner, Gilda Tachedjian, Musa Mhlanga, Rachel A. Davey, Ken C. Pang, Ada S. Cheung, Richard Saffery and Boris Novakovic. ‘Remodelling of the plasma proteome by sex hormones in a longitudinal clinical trial of feminizing gender-affirming hormone therapy,’ Nature Medicine. DOI: 10.1038/s41591-025-04023-9
*The content of this communication is the sole responsibility of MCRI and does not reflect the views of the NHMRC.
Available for interview:
Associate Professor Boris Novakovic, MCRI Team Leader, Molecular Immunity
Professor Ada Cheung, University of Melbourne Head, Trans Health Research Group
END
How do mammals manage to eat in situations that cause anxiety, step into exposed spaces, or slow down when anxiety drives them to keep moving? A new study pinpoints a leptin-sensitive circuit in the lateral hypothalamus that helps to overcome anxiety to perform essential behaviours such as exploring, feeding, and limiting maladaptive hyperactivity. Leptin is a hormone that acts in the brain, regulating energy balance, influencing appetite and eating behaviour. Leptin is sensed by neurons which have leptin receptors. Many of ...
In the right combinations and conditions, two-dimensional materials can host intriguing and potentially valuable quantum phases, like superconductivity and unique forms of magnetism. Why they occur, and how they can be controlled, is of considerable interest among physicists and engineers. Research published in Nature Physics reveals a previously hidden feature that could explain how and why enigmatic quantum phases emerge.
Using a new terahertz (THz) spectroscopic technique, the researchers revealed that tiny stacks of 2D materials, found in research labs around the world, can naturally form what are known as cavities. These cavities confine light and electrons into even ...
Bethesda, MD (Oct. 17, 2025) — The American Gastroenterological Association (AGA) today released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer (adenocarcinoma), a highly lethal cancer whose incidence has risen substantially over recent decades. The guideline provides eight evidence-based recommendations and several key implementation statements to help clinicians monitor patients after a diagnosis of Barrett's esophagus, a condition associated with chronic ...
By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for years. But until recently, scientists didn’t understand which brain cells were being targeted or when the injury began.
Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture yet of when the disease attacks the myelin sheath that covers the nerve fibers. It shows that the immune system begins attacking ...
Some ancient marine organisms produced mysterious magnetic particles of unusually large size, which can now be found as fossils in marine sediments. An international team has succeeded in mapping the magnetic domains on one of such ‘giant magnetofossils’ using a sophisticated method at the Diamond X-ray source. Their analysis shows that these particles could have allowed these organisms to sense tiny variations in both the direction and intensity of the Earth’s magnetic field, enabling them to geolocate themselves and ...
Embargoed until 4 a.m. CT / 5 a.m. ET Monday, Oct. 20, 2025
DALLAS, Oct. 20, 2025 — About 9 in 10 U.S. adults have not heard of cardiovascular-kidney-metabolic (CKM) syndrome, a newly defined health condition affecting nearly 90% of adults that includes heart disease, kidney disease, diabetes and obesity, according to a new survey from the American Heart Association, a relentless force changing the future of health for everyone everywhere. However, many are interested in learning more about it.
Nearly 90% of U.S. adults have at least ...
PITTSBURGH, October 20, 2025 — Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don’t respond to medication and aren’t candidates for surgery. Their approach, published today in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient’s unique brain wiring.
Epilepsy affects more than 50 million people worldwide, and about a third of those do not respond to medication. For some, seizures are generated in parts of the brain that control essential functions – speech, movement or vision – that can’t be safely removed. Brain ...
If you’ve ever added liquid to a hot frying pan, maybe you noticed how the droplets bubbled up and skittered across the sizzling surface, rather than immediately flattening and wetting. This happens because the pan’s heat starts boiling the undersides of the droplets, producing vapor that acts as an insulating cushion on which they can – momentarily – dance.
Previously, scientists have produced a room-temperature version of this phenomenon – known as the Leidenfrost effect – ...
Note: Abstract #6267, titled ECOG-ACRIN EA6174: Surgically Treated Adjuvant Merkel Cell Carcinoma with Pembrolizumab, is scheduled to be presented during the European Society for Medical Oncology meeting on Monday, Oct. 20, at 2:30 a.m. ET in the Cologne Auditorium, Messe Berlin, Berlin.
A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form of skin cancer from spreading to other organs when given immediately after surgery, a new study shows.
Led by researchers at NYU ...
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body’s immune system to target and eliminate cancer cells appeared to reduce the risk of distant metastases for an aggressive form of skin cancer when given immediately after surgery, but did not significantly reduce the overall risk of recurrence, which was a co-primary endpoint of the trial. The randomized phase 3 STAMP trial (EA6174) is the largest clinical study to date evaluating pembrolizumab, ...
